Refactoring of a Synthetic Raspberry Ketone Pathway with EcoFlex by Moore, Simon J et al.
Kent Academic Repository
Full text document (pdf)
Copyright & reuse
Content in the Kent Academic Repository is made available for research purposes. Unless otherwise stated all
content is protected by copyright and in the absence of an open licence (eg Creative Commons), permissions 
for further reuse of content should be sought from the publisher, author or other copyright holder. 
Versions of research
The version in the Kent Academic Repository may differ from the final published version. 
Users are advised to check http://kar.kent.ac.uk for the status of the paper. Users should always cite the 
published version of record.
Enquiries
For any further enquiries regarding the licence status of this document, please contact: 
researchsupport@kent.ac.uk
If you believe this document infringes copyright then please contact the KAR admin team with the take-down 
information provided at http://kar.kent.ac.uk/contact.html
Citation for published version
Moore, Simon J.   (2021) Refactoring of a Synthetic Raspberry Ketone Pathway with EcoFlex.
  Microbial Cell Factories .       (In press)
DOI




Moore et al. Microb Cell Fact          (2021) 20:116  
https://doi.org/10.1186/s12934-021-01604-4
RESEARCH
Refactoring of a synthetic raspberry ketone 
pathway with EcoFlex
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Paul S. Freemont1,3,6,7*  
Abstract 
Background:  A key focus of synthetic biology is to develop microbial or cell-free based biobased routes to value-
added chemicals such as fragrances. Originally, we developed the EcoFlex system, a Golden Gate toolkit, to study 
genes/pathways flexibly using Escherichia coli heterologous expression. In this current work, we sought to use EcoFlex 
to optimise a synthetic raspberry ketone biosynthetic pathway. Raspberry ketone is a high-value (~ £20,000  kg−1) fine 
chemical farmed from raspberry (Rubeus rubrum) fruit.
Results:  By applying a synthetic biology led design-build-test-learn cycle approach, we refactor the raspberry 
ketone pathway from a low level of productivity (0.2 mg/L), to achieve a 65-fold (12.9 mg/L) improvement in pro-
duction. We perform this optimisation at the prototype level (using microtiter plate cultures) with E. coli DH10β, as a 
routine cloning host. The use of E. coli DH10β facilitates the Golden Gate cloning process for the screening of combi-
natorial libraries. In addition, we also newly establish a novel colour-based phenotypic screen to identify productive 
clones quickly from solid/liquid culture.
Conclusions:  Our findings provide a stable raspberry ketone pathway that relies upon a natural feedstock (L-tyros-
ine) and uses only constitutive promoters to control gene expression. In conclusion we demonstrate the capability 
of EcoFlex for fine-tuning a model fine chemical pathway and provide a range of newly characterised promoter tools 
gene expression in E. coli.
Keywords: Synthetic biology, Fine chemicals, Tyrosine, Raspberry ketone, Golden Gate, E. coli
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco 
mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ 
zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Introduction
Synthetic biology aims to refactor synthetic pathways—
in synchrony with a cell’s need to grow and divide—as 
it seeks to provide biosustainable routes to value-added 
chemicals and biopharmaceuticals. Recent examples 
include vanillin [1], menthol [2] and semi-synthetic 
drugs such as artemisinin [3] and taxol [4]. Engineering 
fine chemical pathways in chassis such as Escherichia 
coli, often disrupts cell homeostasis [5]. Foreign enzymes 
that have evolved under a different context—within 
thermophiles, plants, fungi, archaea—may cause unpre-
dictable knock-on effects including: poor kinetics, 
requirement of cofactors/metals [6], sub-optimal gene 
expression and/or protein folding, while codon content 
and cryptic regulatory features can lead to gene expres-
sion problems. To some degree the latter can be allevi-
ated with codon-optimisation, although this can lead to 
rapid translation, which also carries a penalty. In general, 
these imbalances drain core resources and reduce growth 
rates. Depending on the synthetic pathway, individual 
products or intermediates, can also cause toxicity [7]. In 
this scenario, pathway bottlenecks may require engineer-
ing, such as efflux proteins to pump out toxic products 
[8]. To navigate some of these issues, synthetic biol-
ogy can refactor gene expression to fine tune individual 
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enzyme levels and increase efficiency of a chosen path-
way, and some extent, minimise toxic effects in harmony 
with host metabolism [9]. To achieve this, combinatorial 
DNA assembly is routinely used to control individual 
gene expression elements: promoters, insulators, open-
reading frames (ORF), ribosome-binding sites (RBS) and 
terminators. Previously, we released EcoFlex, an modular 
cloning toolkit for flexible cloning and pathway optimi-
sation [10]. EcoFlex is a Golden Gate based hierarchical 
workflow for cloning genes (Level 1) and pathways (Level 
2–3) for expression in E. coli. In this work we sought to 
deploy EcoFlex to tackle a high-value fine chemical path-
way. We chose a 4-(4-hydroxyphenyl)butan-2-one path-
way, also referred to as raspberry ketone, as a model 
pathway to optimise.
Natural raspberry ketone is farmed from Rubeus 
rubrum in a number of developing countries, which 
amongst a range of naturally sourced products, contrib-
utes to deforestation. Approximate yields of 1  g rasp-
berry ketone per hectare of land (~ 1000 kg of fruit) are 
typically obtained [11]. This presents a highly inefficient 
purification process, which is reflected by a high market 
price for naturally extracted raspberry ketone—between 
$10,000–20,000  kg−1. Microbial heterologous production 
of raspberry ketone has resulted in titres from 1–91 mg/L 
using E. coli [11–13]. The best strategy requires growth 
on rich media and a high powered T7 promoter driven 
gene expression. Alternatively, a semi-synthetic whole-
cell approach was recently used to bypass cell toxicity 
and make raspberry ketone to the gram per litre scale 
in E. coli [14]. To engineer a synthetic raspberry ketone 
biosynthetic pathway with EcoFlex, we first considered 
potential factors that may limit its production in E. coli 
and the design of the pathway: supply of the substrate 
provision (most studies feed p-coumarate); limited pool 
of malonyl-CoA (~ 35  μM) in E. coli [15]; and poten-
tial bottleneck steps, especially for the type III polyke-
tide enzyme—benzalacetone synthase (kcat = 0.1   s−1) 
[16]. Moreover, both raspberry ketone and to a greater 
extent, the precursor 4-hydroxybenzalacetone (HBA) 
are toxic to cell growth [11]. On this basis, we selected 
a five-step synthetic pathway to optimise with EcoFlex. 
We initially screened a combinatorial promoter and RBS 
library. From our initial exploration three issues emerged: 
low success rate, low titres and loss of pathway genes 
through homologous recombination at the promoter and 
terminator regions. While we could vary the Rho-inde-
pendent synthetic terminators, by selecting them from a 
library originally developed for resistance to homologous 
recombination [17], we desired further control at the pro-
moter region. Therefore, in this work, we newly develop a 
degenerate σ70 promoter library to fine-tune enzyme lev-
els. To overcome the initial low hit rates, we also identify 
a novel colour-based screening approach to identify opti-
mal promoter design space for production of a raspberry 
ketone precursor, and individually tailor each enzyme 
level to provide maximal metabolic flux balanced with 
minimal promoter strength; this reduces resource usage 
and metabolite toxicity in the system. Overall, we provide 
a 65-fold improvement (up to 12.9  mg/L) in raspberry 
ketone production in E. coli. In conclusion, we report the 
refactoring of a synthetic raspberry ketone pathway, as 
an example of a synthetic biology design-build-test-learn 
approach to engineering a toxic fine chemical pathway in 
E. coli.
Results and discussion
Refactoring in E. coli identifies pathway bottlenecks 
and genetic instability
Based on available literature, we designed a synthetic 
raspberry ketone pathway (see material and methods), 
from plant, bacterial and fungal sources. The pathway 
begins from L-tyrosine, which is an endogenous primary 
metabolite, for expression in E. coli. The four-step path-
way uses tyrosine ammonia lyase (TAL), p-coumaroyl-
CoA ligase (PCL), benzalacetone synthase (BAS) and a 
NADPH-dependent raspberry ketone synthase (RKS). 
To complement this, we also selected a malonyl-CoA 
synthetase (MatB) for malonyl-CoA regeneration from 
malonate, CoA and ATP (17).
To begin, we built a plasmid with each gene under the 
control of the low-strength J23114 promoter (pJ23114-
RK) and a strong RBS (PET-RBS), and tested it in a num-
ber of E. coli strains. We rationalised that using a weak 
promoter strength should provide sufficient levels of 
raspberry ketone to detect, allowing us to optimise the 
pathway by testing stronger promoters. Unexpectedly, 
the recA− deficient E. coli DH10β cloning strain pro-
vided the highest yields over other common laboratory 
strains (Additional file  1: Figure S1). In addition, provi-
sional experiments in different media (M9, M63, LB, 2YT 
and TB) confirmed that the E. coli DH10β pJ23114-RK 
plasmid strain was only productive in rich media (data 
not shown). Raspberry ketone production in minimal 
media was below the limit of detection on HPLC–MS. 
While minimal media is preferred for standardisation in 
synthetic biology, within the context of our experiment, 
we decided to continue with rich media (2YT) for all 
experiments including promoter and enzyme characteri-
sation. Poor raspberry ketone production has also been 
previously reported in minimal media [11, 13]. Finally, 
we also observed only trace levels of raspberry ketone 
in either batch or in high cell density fermenter growth 
in the semi-defined SM6 media (Additional file 1: Figure 
S2), which we performed with our final optimised strain 
described later.
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Next, we continued with E. coli DH10β as a heter-
ologous host and 2YT medium supplemented with 
10  mM malonate (for MatB catalysed malonyl-CoA 
regeneration) for screening. Then we made a selec-
tion of pathway variants to identify potential bottle-
necks. Simultaneously, we attempted to assemble five 
pathways (tal-pcl-matB-bas-rks) with MoClo, each 
varied with one gene controlled by a strong J23100 
promoter, with the remaining four genes under the 
control of weak strength J23114 promoter. Interest-
ingly, after MoClo assembly of J23100-tal and J23114-
pcl, J23114-bas, J23114-matB and J23114-rks, after 
E. coli transformation, a range of colony sizes were 
obtained. Despite several attempts, we were unable 
to isolate the desired pathway combination, suggest-
ing this design was unstable due to overproduction of 
TAL. However, the remaining four pathway variants 
were obtained with a weak J23114 promoter for tal 
expression, while the pcl, bas, matB and rks genes were 
individually overexpressed with the strong J23100 pro-
moter to increase gene expression. Interestingly, with 
J23100-pcl (and J23114-tal, J23114-bas, J23114-matB 
and J23114-rks), the pathway was inactive—no p-cou-
marate, HBA or raspberry ketone was detected. How-
ever, since our LC–MS analysis does not include the 
intracellular intermediate p-coumaroyl-CoA (pCA-
CoA), we are unsure why this variant disrupts path-
way flux. To test this further, we also built a three-gene 
pathway (tal, pcl, and bas) solely with a J23100 pro-
moter, in an attempt to maximise HBA levels. Interest-
ingly, this variant pathway only produced trace levels 
of either p-coumarate (~ 0.5  μM) or HBA (~ 0.5  μM), 
while the level of the L-Tyr substrate remained unal-
tered in comparison to an empty vector control. Next, 
for the strong J23100-bas variant, HBA (9  μM) levels 
increased 4.7-fold in comparison to the low strength 
promoter positive control strain (1.9 μM), confirming 
that BAS (expression and activity) is rate-limiting [11, 
16]. At this level of HBA production, there was a sig-
nificant (24.7%) decrease in the final  OD600 of cultures 
grown for 48 h (p value = 0.02); we suspect this is due 
to HBA accumulation and/or gene expression toxicity 
from overproduction of BAS. Next, with J23100-matB 
(all other genes J23114), pathway activity remained 
unchanged. Finally, with J23100-rks, there was com-
plete flux of HBA into raspberry ketone (2.7  μM), 
which confirmed that RKS strongly favours product 
formation. In summary, these findings suggested the 
pathway could be improved using EcoFlex. However, 
since the BAS enzyme represents a key bottleneck, we 
next sought to optimise this step.
A rapid pigment screening strategy for HBA/raspberry 
ketone production
A key problem with fine chemical pathways is the lack 
of a fast, high-throughput method to optimise path-
way design; raspberry ketone is colourless and requires 
analytical methods such as HPLC for detection. Inter-
estingly, a retro-aldol synthesis of the precursor HBA 
[18], revealed this to be a yellow-orange powder, which 
broadly absorbs between ~ 300–450  nm in neutral-alka-
line conditions (> pH 7.5) but is colourless below pH 7. 
Importantly, despite some absorbance between 260–
350 nm, none of the other pathway intermediates such as 
L-Tyr (colourless), p-coumarate (pale yellow) or p-cou-
maroyl-CoA (pale yellow) or raspberry ketone (colour-
less) shares this distinct visual spectral property. Based 
on this observation, we tested if we could monitor HBA 
production using EcoFlex, by first optimising the concen-
trations of only the first three genes, tal, pcl and bas to 
maximise HBA accumulation. To simplify this further, we 
also omitted the malonyl-CoA regeneration scheme since 
the E. coli malonyl-CoA pool is ~ 35 µM [15] and the BAS 
enzyme has a favourable KM (23.3 μM) for malonyl-CoA 
[16]. Therefore, at low (~ µM) levels of flux, we did not 
expect malonyl-CoA to be rate-limiting. Next, we ini-
tially built the pathway with a random promoter library 
containing ten low to high-strength EcoFlex σ70 promot-
ers into a medium-copy (ColE1) origin of replication 
pTU2-A destination vector, while also adding a kanamy-
cin marker as an additional selective pressure to maintain 
plasmid stability. After three days of incubation at 30 °C 
on 2YT plates, we observed a range of white-, yellow- and 
orange-coloured colonies (typically ~ 100–1000 per E. 
coli transformation). To continue, we picked 32 colonies 
that displayed strong yellow-orange pigmentation and 
grew in small-scale liquid culture (Figs.  1, 2). Interest-
ingly, a number of the strains all but depleted the L-Tyr 
substrate (~ 1.6–2.3  μM) and had high levels of p-cou-
marate (154–180 μM), but no HBA or raspberry ketone. 
In addition, two strains had increased HBA levels up to 
68 μM, and 14 μM raspberry ketone from an unidentified 
and non-specific E. coli alkene reductase [11]. Overall, all 
strains producing HBA had a weak promoter with the pcl 
gene (J23114, SJM914), while the bas gene had either a 
medium (SJM908, SJM910) or strong promoter (J23100). 
However, this new library also contained a number of 
recombination events between the pcl and bas genes, but 
only where the J23114 promoter was found preceding the 
pcl gene. This is probably due to its frequent occurrence 
within the library, as a weak strength promoter. From 
recent literature [19], this was due to the repetitive use 
homology between the promoters and the Bba_B0015 
terminator in the Golden Gate assembly. Therefore, we 
aimed to increase the diversity of terminators used in the 
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next round of assembly. In addition, to fine-tune indi-
vidual enzyme levels, we also desired a wider selection of 
promoters. To achieve this, we built and characterised a 
new σ70 promoter library with degenerate bases to mini-
mise homologous recombination.
Characterisation of a new EcoFlex promoter library
Ultimately, our final goal was to create an optimised path-
way using constitutive promoters, rather than inducible 
promoter control. We were intrigued by the disturbances 
in growth for some pathway constructs in response 
to stronger promoters and whether this is  a common 
observation between different pathway enzymes. There-
fore, we explored potential design faults at the level of 
individual gene expression for the first three pathway 
enzymes (TAL, PCL and BAS), which are responsible for 
HBA biosynthesis. To provide new variable strength σ70 
promoters with reduced homology, we also expanded 
the EcoFlex promoter library [10]. This is based on the 
original Anderson promoter library [20] with degeneracy 
within the −  35 and −  10 boxes. In addition, to reduce 
homologous recombination, we also included two sepa-
rate degenerate regions within the promoter. To assess 
how the new degenerate σ70 promoters control E. coli 
growth and the synthesis of specific proteins within the 
raspberry ketone pathway, we characterised eight σ70 
promoters, spanning from low (1% activity relative to 
J23100) to high (SJM935—113%) activity  (Additional 
Fig. 1 A comparison of raspberry ketone biosynthesis in vitro and in vivo identifies pathway limitations. A Biosynthetic pathway for raspberry 
ketone and Kcat values are referenced within the main text. Intermediates quantified throughout LC–MS include L-tyrosine (white box), p-coumarate 
(yellow box), HBA (orange box) and raspberry ketone (red box). B EcoFlex refactoring of the raspberry ketone pathway. See methods for details of 
growth conditions. Data and error bars (standard deviation) is representative of three biological repeats
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file  1: Table  S1). To monitor relative protein synthe-
sis, we created a C-terminal eGFP translational fusion 
with the TAL, PCL and BAS proteins and monitored 
growth and fluorescence (Fig.  3B). As expected, the 
strongest promoter (SJM935) gave the strongest lev-
els of eGFP fluorescence for both TAL and BAS. How-
ever, over two independent measurements, we observed 
strong variability in both growth and fluorescence 
(Fig. 3B) between the datasets for the strongest promot-
ers (SJM935 and J23100) in contrast to more consistent 
growth for the low-medium strength variants. For exam-
ple, some biological repeats for both SJM921-tal-eGFP 
and SJM921-bas-eGFP spontaneously lost GFP fluores-
cence during growth and demonstrated major lag times 
(> 2–4 h), before late exponential growth and loss of flu-
orescence. In addition, colonies from these clones were 
variable in size and smaller on average. This suggested 
strong promoter-gene combinations accumulate spon-
taneous mutations or loss of the plasmid during growth. 
While we did not investigate this observation in detail, 
we acknowledge that E. coli DH10β has a high back-
ground mutation rate, 13.5-fold higher than MG1655 
[21]—the likely cause of genetic instability in response 
to toxicity. Intriguingly, these growth observations were 
also dependent on the gene studied. For example, for the 
PCL-eGFP fusions, while the final cell density decreased 
with increasing promoter strength for PCL variants, we 
did not observe any major variations in growth or fluo-
rescence between biological repeats. This may be reflec-
tive of a specific level of toxicity to the system, which 
in the case of TAL, is likely due to depletion of L-tyros-
ine as a core metabolite. The case for the toxicity with 
single gene overexpression of bas is less clear but may 
be linked to differences in translation elongation/ribo-
some occupancy. While there was a clear trend between 
eGFP characterised promoter strength and fluorescence 
for the PCL-eGFP and BAS-eGFP fusion proteins, we 
were intrigued by the distinct and variable findings with 
TAL-eGFP (Fig. 3A). Therefore, we sought to investigate 
the gene-eGFP fusions separately using denaturing SDS-
PAGE to assess fusion protein solubility. To do this, we 
selected plasmid strains with either a low, medium or 
high-strength promoter for the tal-gfp, pcl-gfp and bas-
gfp fusions and analysed intracellular proteins by dena-
turing PAGE (Additional file 1: Figure S3). Firstly, all GFP 
fusions were synthesised at the expected molecular size. 
Under a high-strength promoter (SJM935—113%), all 
three fusion proteins were predominantly located in the 
insoluble fraction rather the soluble fraction. In particu-
lar, in comparison to TAL, the relative levels of insoluble 
protein for PCL and BAS decreased from the SJM935 
promoter plasmids. Non-specific protein aggregation is 
a common issue with strong heterologous protein pro-
duction in E. coli [22]. In contrast, both the low-strength 
(SJM942—18%) and medium-strength (SJM964—56%) 
promoter combinations gave major bands on SDS-
PAGE for the soluble enzyme-GFP fusions (Additional 
file 1: Figure S4) and there was much less fusion protein 
observed in the insoluble fractions (Additional file 1: Fig-
ure S4). Therefore, as expected, the strongest promoters 
favour formation of inclusion bodies and drain resources 
quicker, resulting in decreased growth rates. In summary, 
these results confirmed that the characterisation of indi-
vidual gene-fusions differ in relation to enzyme function 
Fig. 2 Development of colour-based phenotypic screen for HBA production. Pathway design of the HBA module with a secondary marker 
(kanamycin resistance) and promoter library assembly. Yellow-orange colonies that were used for selection of active pathway variants were 
identified after ~ 3 days of growth at 30 °C on 2YT agar supplemented with 50 mM Tris–HCl pH 8 buffer, followed by liquid growth (from triplicate 
single colonies) and quantification of pathway intermediates by LC–MS. Sequencing summary is provided in Additional file 1: Table S2. Data and 
error bars (standard deviation) is representative of three biological repeats
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and the state of protein folding within the cell. This is a 
form of context dependency, which is an increasingly 
important factor in the design of genetic circuits and 
pathways in synthetic biology [23]. Next, with this new 
knowledge, we set upon refactoring the pathway to opti-
mise raspberry ketone production.
Refactoring an optimised raspberry ketone pathway
To reach a balanced pathway, we next separately opti-
mised the pathway as two modules, HBA biosynthesis 
and HBA reduction (raspberry ketone synthesis), before 
joining this together in a final assembly. We started with 
a focused library to fine-tune HBA synthesis (Fig.  4) 
applying the following rationale. Firstly, high synthesis 
of TAL leads to toxicity and the formation of inclusion 
bodies. However, since TAL has a relatively low catalytic 
rate and a high  KM for L-Tyr, we selected six medium–
high strength σ70 promoters (SJM964, SJM926, SJM923, 
SJM936, SJM942, SJM933) for the tal gene. Secondly, 
PCL is a highly efficient enzyme, while too much inac-
tivates the pathway. Therefore, six low-strength σ70 pro-
moters (SJM940, SJM924, SJM956, SJM947, SJM952, 
SJM949) were paired with the pcl gene. Finally, we knew 
BAS was rate-limiting from all previous experiments, 
while high synthesis leads to formation of inclusion bod-
ies and plasmid instability. Therefore, bas was paired 
with six medium–high strength σ70 (SJM928, SJM931, 
SJM935, J23100, SJM937, SJM941) promoters to pro-
vide a trade-off between growth and performance. The 
advantage of using a focused promoter strategy is that 
the library can be populated with only a finite range of 
desirable promoter strengths, whereby the fastest grow-
ing clones (e.g., those with low-strength promoters) will 
not dominate within libraries. The rational selection of 
parts also reduced the library size from  103 in to  63. Addi-


































































































































































































































Fig. 3 Characterisation of promoter activity with HBA module enzymes with a C-terminal GFP translational fusion. A Design of a degenerate σ70 
promoter library for characterisation with eGFP in microplate conditions, for full details see methods. B Promoter characterisation with HBA module 
enzyme fusions. Black bars represent  OD600, while coloured (pink/green/blue) bars represent eGFP fusions in terms of relative expression rate during 
exponential growth (GFP  hr−1). Data is representative of two technical readings and four biological repeats grown from single E. coli colonies. Error 
bars represent standard deviation
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(Bba_B0015, L3S1P51, L3S2P21) to minimise homolo-
gous recombination [9] and held the RBS position 
constant (PET-RBS). After assembly and E. coli transfor-
mation of the second library, we repeated the screening 
process by selecting 20 colonies displaying yellow-orange 
pigmentation. After growth, LC–MS analysis revealed 
that the strains produced a wide range of p-coumarate 
levels (21–153 μM) with strong production of both HBA 
(36–98  μM) and raspberry ketone (31–96  μM) (Fig.  4). 
From sequencing, we found nine clones were duplicated 
within the library, but importantly, the level of the path-
way intermediates between these clones were very simi-
lar. Unexpectedly, we found that clones, 6, 10, 14, and 
18 contained a novel promoter sequence driving expres-
sion of the pcl gene that was not part of the characterised 
library. The promoter (SJM965, see Additional file 1) con-
tained a single-base pair deletion and a novel randomised 
region between the -10 and -35 sequences. Sequencing 
data from the library was clean, suggesting this promoter 
must have been present at low levels, but was strongly 
selected for in our phenotypic screen. Interestingly, 
despite an average decrease in final  OD600 (48 h) of 21% 
(range 3.7–4.7) in comparison to an empty vector control 
 (OD600 = 5.03) (Additional file  1: Figure S4), the path-
ways in all clones were stable based on Sanger sequenc-
ing (Additional file  1: Figure S5). For example, we did 
not identify any homologous recombination events and 
there was a clear absence of mutations with the regions 
sequenced (e.g., promoter, RBS and terminator regions). 
A summary of the sequencing is provided within the 
Additional file 1: Figure S5 and Table S2). Satisfied with 
this outcome, we next looked at optimising the reduc-
tase module, which could then be added to complete the 
pathway.
To assess the double bond reductase, we paired the 
rks gene with five low to strong σ70 promoters, PET-RBS 
and a L2U2H09 terminator into pTU1-D-lacZ. The vari-
ants were grown in microtitre plates at 30 °C for 24 h and 
assessed for growth-rate, final  OD600 and activity with 
1 mM HBA substrate (Additional file 1: Figure S6). 1 mM 
HBA led to a 57% reduction in  OD600 (Fig. 5), across the 
different rks promoter and empty-vector control strains 
(Fig. 5). In terms of HBA flux, four out of five of the pro-
moter variants (high-low strength) gave 99.9% conversion 
of HBA into raspberry ketone (Fig. 5), with only the low-
est strength promoter (SJM961—1% activity relative to 
J23100) leading to low conversion into raspberry ketone: 
21.3 vs 13.9% with an empty vector control. Interestingly, 
the final  OD600 was stable with increasing the RKS pro-
moter strength (Fig. 5).
Next, we formed the final pathway design by combin-
ing two of the strongest HBA modules (B6 and B12 from 
Fig. 4), the optimised reductase module (from Fig. 5) and 
a separate malonyl-CoA regeneration module (Fig.  6). 
For the latter module, we aimed to increase the sup-












































Fig. 4 Optimisation of the HBA module with the new promoter 
library. Promoter fine-tuning of the HBA module. Six degenerate σ70 
promoters were selected for EcoFlex assembly with each pathway 
gene, E. coli DH10β was transformed and grown on 2YT agar with 
antibiotics for 3 days at 30 °C. Colonies with distinct yellow-orange 
colouration were grown and quantified for pathway intermediates 
as described in the methods. The low-strength pathway (J23114-RK) 
and an empty plasmid control (pTU1-A) were tested for relative 
comparison. Data and error bars (standard deviation) is representative 
of three biological repeats. Sequencing summary is provided in 


















































Fig. 5 Promoter fine-tuning of the reductase module. Single 
promoter variants with the rks gene were grown in 1 mL 2YT media 
with antibiotics, at 30 °C, both with and without 1 mM HBA in a 
12-well plate and monitored for growth  (OD600) and LC–MS. Data and 
error bars (standard deviation) is representative of three biological 
repeats
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Rhizobium trifolii matC (malonate transporter) gene 
in combination with matB (described earlier) under a 
low strength promoter in the final plasmid design. This 
strategy has previously been employed successfully for 
other flavonoid natural products [24, 25]. Additionally, 
we also introduced a sfGFP fluorescence reporter to 
monitor relative pathway stability, to act as an indica-
tor of genetic stability [5]. To measure pathway stability 
and the drain of the plasmid system on general protein 
synthesis, we used a superfolder GFP (sfGFP) reporter, 
under the control of kasOp* promoter; a Streptomyces 
σ70 promoter that is strongly active in E. coli at low levels. 
Next, this final plasmid strain was assessed for growth 
and fluorescence to monitor for growth and plasmid 
stability (Fig.  6). The relative fluorescence of the strains 
was very similar between individual repeats, which sug-
gested the strains were stable. However, relative fluo-
rescence was reduced by 70% (Fig.  6) in comparison to 
the vector control (pTU1-A-kasOp*-sfGFP), which sug-
gested that regardless of pathway productivity, the extra 
genes within the plasmid design (eight in total) cause a 
major drain on net protein synthesis. This was reflected 
by a decrease in the sfGFP reporter fluorescence and 
a delay of 4  h for lag  growth time. Finally, we charac-
terised the strain for relative protein levels (Fig.  6) and 
raspberry ketone production. SDS-PAGE revealed TAL 
accounts for ~ 10–20% of all intracellular proteins (Addi-
tional file  1: Figure S7), while BAS and RKS were also 
clearly overproduced (Additional file 1: Figure S7). At the 
metabolite level, we observed a clear 67–81% decrease in 
the L-tyrosine substrate relative to the control, 54–67 μM 
for p-coumaric acid, ~ 1 μM HBA and 63–78 μM (10.8–
12.9  mg/L) of raspberry ketone, respectively, in small-
scale (5 mL 2YT) batch conditions. Additionally, we also 
did separate experiments to test the effect of malonate 
on malonyl-CoA regeneration, but we found this was not 
significantly limiting for raspberry ketone production in 
E. coli (Additional file 1: Figure S8). This might be due to 
the kinetic properties of the BAS enzyme, which has a 
low KM (23.3 μM) for malonyl-CoA [16] and is favourable 
for E. coli to replace under homeostasis. Overall, from 
starting with an initial design that produced barely trace 
levels of raspberry ketone (0.2 mg/L), we have achieved a 
maximum 65-fold (12.9 mg/L) improvement in titre and 
have produced a stable pathway using only constitutive 
expression.
Conclusions
Currently, an array of fine chemicals and medicinal com-
pounds require chemical synthesis or extraction from 
the natural source, which can be costly, inefficient or 
require extensive agricultural land—this is especially 
important as we transition to a sustainable bioeconomy. 
A key aim for synthetic biology within the next decade 
or so [26] is the replacement of these strategies using effi-
ciently engineered microbial or plant chassis. Our work 
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Fig. 6 Level 3 assembly of the final optimised strain with a malonyl-CoA regeneration module, optimised reductase step and a pathway 
stability monitor. The plasmid strains were assessed for growth and eGFP fluorescence in 96-well microtitre plates, as well as LC–MS for pathway 
intermediates (representative of six biological repeats). Error bars represent standard deviation. The plasmid strains (pRK-B6 and pRK-B12) 
correspond to the B6 and B12 HBA modules, shown in Fig. 4 and Additional file 1: Table S5. The control plasmid (pTU1-A) is pTU1-D-kasOp*-sfGFP. 
Further details are described in methods
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demonstrates a strategy to reduce the pressures of tox-
icity frequently encountered in routine DNA assembly 
workflow: here we used our  EcoFlex MoClo platform. 
This is a frequent but understudied issue [5, 27] with han-
dling toxic fine chemical pathways, and of broad interest 
to synthetic biology. Our EcoFlex library provides stable 
pathway expression for the product pathway, raspberry 
ketone using only constitutive control of individual path-
way genes; this is more favourable than inducible pro-
moters for industrial application [28]. However, further 
work is required to establish production under minimal 
medium conditions to exploit potential bioconversion 
of renewable feedstocks for value-added production of 
natural raspberry ketone. This is potentially achievable 
since the E. coli L-tyrosine pool can be engineered to the 
g/L scale [29]—a key requirement for industrial appli-
cation. In addition, detoxication strategies may also be 
required such as the use of self-resistance mechanisms 
[8] or direct chemical processing via continuous extrac-
tion methods [30]. In conclusion, we provide an upgrade 
to our original EcoFlex MoClo system for the rapid opti-
misation of a toxic fine chemical in E. coli, by refactoring 
pathway expression to the minimum level for maximum 
pathway flux and minimal resource drainage.
Materials and methods
Molecular biology and general methods
All standard molecular biology, routine growth condi-
tions and antibiotic concentrations are described in a 
previous publication (EcoFlex). All primers used are 
listed in the Table S3. For preparation of promoter librar-
ies, 50 ng of each promoter part was included in a Level 
1 MoClo reaction. 25  µL of commercial chemical com-
petent DH10β (NEB) cells were transformed with one-
third (5  µL) of the reaction mixture, using routine heat 
shock method and then recovered for 1 h with 200 µL of 
SOC  medium. 50  µL of this mixture was directly incu-
bated in 10  mL LB with ampicillin (10  μg   mL−1) and 
grown for 16 h at 30 °C. Plasmid DNA was purified and 
sequenced (SourceBioscience).
σ70 degenerate library
Forward primer Sigma70_11N_R and reverse primer 
Sigma70_F (see Additional File 1: Table S4) were used to 
amplify the library from the template pSB1C3-J23100-
eGFP, as described in our previous publication [10].
HBA synthesis
A 20% (w/v) solution of NaOH (2.00 g NaOH in 10 mL 
 ddH2O) was cooled in an ice water bath. Base solution 
was added dropwise into 4-hydroxybenzaldehyde (2.00 g, 
16.38 mmol) in acetone (12 mL) over 5 min. The resulting 
yellow solution was stirred in the ice bath for a further 
10 min, and then at room temperature for 16 h. The reac-
tion was quenched with 50 mL of ice-water mixture and 
cooled in an ice water bath. Concentrated HCl (15  mL) 
was added to adjust the pH to 1. The mixture was con-
centrated in vacuo and extracted with ethyl acetate 
(2 × 100  mL). The ethyl acetate extracts were washed 
with  ddH2O (1 × 50  mL), brine (1 × 75  mL) and dried 
with  Na2SO4. Normal phase purification (ethyl acetate: 
hexane gradient 2–40%), provided a yellow crystalline 
solid (2.02  g, 76% yield). HBA was synthesised using a 
published method [18] and NMR spectra (Additional 
file 1: Figure S6) agrees with published literature.
HBA screening and analysis
For the HBA pathway screening, the transformation 
mixtures were grown for 48–72 h at 30 °C  on modified 
2YT agar (Melford) until pigmentation was observed. 
Modified 2YT liquid medium was adjusted to pH 8 with 
50 mM Tris base and HCl, before addition of 15 g  L−1 of 
technical agar (Melford) to enhance colour detection. A 
reduced concentration of chloramphenicol (20 µg  mL−1) 
and kanamycin (20  μg   mL−1) was used for pathway 
screening and all liquid cultures. For growth, fluores-
cence and LC–MS measurements, standard 2YT medium 
was used. For LC–MS analysis, three single colonies 
(from E. coli transformations) were grown in in 5  mL 
2YT for biological repeats. Samples for HPLC–MS were 
measured twice to ensure MS signals were stable over the 
measurement time period.
Gene synthesis
Rhodotorula glutinis tal, Arabidopsis thaliana pcl, Rubeus 
rubrum bas, Rhodopseudomonas palustris matB, Rhizo-
bium trifolii matC and Rheum rubrum rks were selected 
for gene synthesis by Life technologies, Invitrogen. The 
genes were codon optimised for E. coli K12 expression 
and compatibility with EcoFlex. Sequences provided in 
Additional file 1.
Denaturing PAGE of intracellular soluble and insoluble 
proteins
DH10β plasmid strains were grown for 24 h at 30 °C. The 
 OD600 was measured and 1  mL of culture was centri-
fuged. The cell pellet was then re-suspended in Buffer A 
with 1 mg  mL−1 lysozyme, 1% Triton X-100 and 50 units/
µL Benzonase® (Millipore) so the cells were concentrated 
to an equivalent  OD600 of 20 and incubated at 30 °C for 
30  min. Lysed cells were then clarified at 18,000 × g, 
4  °C for 10  min to separate soluble and insoluble pro-
tein fractions. 10–50  μg of total protein was then sepa-
rated by denaturing PAGE and stained with InstantBlue 
(Generon).
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Plate reader measurements
For CLARIOStar© (BMG Labtech) plate reader assays, 
a 100 µL 2YT culture volume was grown in quadrupli-
cate biological repeats (e.g. four single colonies) as an 
overnight pre-culture for 16 h. The  OD600 was recorded, 
before dilution into a fresh 96-well plate with 100  µL 
2YT and antibiotics at a starting  OD600 of 0.02. Cell 
density was measured in a plate reader at 600 nm in a 
96-well Greiner plate to a starting  OD600 of 0.02. Plates 
were sealed with a Breathe-Easy® membrane (Sigma) 
and grown at 30  °C for 6–12 h at 600 rpm.  OD600 and 
GFP measurements were recorded every 10  min. The 
experiment was repeated on two independent days to 
ensure reproducibility. Error bars represent standard 
deviation.
LC–MS of raspberry ketone pathway intermediates
For cultures, cells were removed by centrifugation at 
6,000 × g, 4  °C for 10  min. The supernatant was acidi-
fied by addition of 2% (v/v)  HCl, followed by clari-
fication for 18,000 × g, 4  °C for 10  min. For enzyme 
reactions, 50  µL samples were removed and inacti-
vated with 2% (v/v) HCl and centrifuged at 13,000 rpm 
for 10 min at room temperature. Samples were diluted 
with 450  µL  ddH2O. Samples were then directly ana-
lysed by LC–MS, performed with an Agilent 1290 
Infinity system with an online diode array detector in 
combination with a Bruker 6500 quadruple time-of-
flight (Q-ToF) mass spectrometer. An Agilent Extend-
C18 2.1 × 50  mm (1.8  μm particle size) column was 
used at a temperature of 25  °C with a buffer flow rate 
of 0.2   mL−1   min−1. LC was performed with a lin-
ear gradient of buffer A (0.1% formic acid) and buffer 
B (0.1% formic acid in acetonitrile). Separation was 
achieved using 5% buffer B for 2  min, followed by a 
linear gradient to 50% buffer B from 2–9  min, which 
was held at 50% buffer B from 9–10 min. Spectra were 
recorded between a mass range of 90–1000  m/z at a 
rate of 3 spectra per second. Standards were prepared 
and calibration curves for the intermediates L-Tyr, 
p-coumaric acid, HBA and raspberry ketone were 
derived  (Additional File 2). Quantitation was based 
on the MS peak area of precursor or fragment ion in 
comparison to the analytical standards. Under the con-
ditions used, raspberry ketone is detected as a sodium 
adduct [M +  Na+]+ or as a diagnostic fragment ion at 
m/z = 107.49, corresponding to  C7H7O. For the stand-
ards in solvent, good linearity  (R2 > 0.99) was achieved 
over the range of 0.3 to 30 pmol on column. The lower 
limit of quantitation was set at 0.3 pmol. Samples that 
were below this limit were repeated by increasing the 
injection volume to 1 µL. Error bars represent standard 
deviation from three independent biological samples.
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